Shares of ASP Isotopes Inc. (ASPI) surged 11.92% in after-hours trading on Thursday, following the announcement of a significant loan agreement with TerraPower, a leading U.S. nuclear innovation firm. The deal, which aims to support the construction of a new uranium enrichment facility, has sparked investor enthusiasm for the Delaware-based company's future prospects in the nuclear energy sector.
According to the agreement signed on May 16, 2025, TerraPower will provide conditional financial commitments totaling $22 million to ASP Isotopes' subsidiary, QLE TP Funding SPE LLC. The loan, guaranteed by ASP Isotopes Inc. and Quantum Leap Energy LLC, carries a maturity date of May 16, 2032. This financial backing is intended to facilitate the production of High Assay Low-Enriched Uranium (HALEU), a crucial component for advanced nuclear reactors.
The deal also includes a long-term supply arrangement, allowing ASP Isotopes to sell excess HALEU to other buyers if TerraPower doesn't meet certain purchase criteria. This flexibility, combined with the substantial loan amount, suggests a potentially lucrative future for ASP Isotopes in the growing market for advanced nuclear fuel. Investors appear to be reacting positively to this development, viewing it as a significant step forward for the company's growth and market position in the nuclear energy industry.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.